Related Experiment Videos
A serum facted by newborn calf serum
Summary
Newborn calf serum (NBCS) triggers an inflammatory response in mice, leading to a monocytosis-inducing factor in their blood. This factor specifically boosts mononuclear phagocyte production.
Area of Science:
- Immunology
- Hematology
Background:
- Newborn calf serum (NBCS) induces an inflammatory reaction in mice.
- This reaction is characterized by increased peritoneal macrophages and peripheral blood monocytosis.
Purpose of the Study:
- To investigate the presence and nature of a monocytosis-inducing factor in the serum of mice injected with NBCS.
- To determine the specificity and characteristics of this factor.
Main Methods:
- Intraperitoneal injection of NBCS into mice.
- Collection and intravenous injection of serum (CalS18, CalS24) from treated mice into test mice.
- Analysis of blood cell counts (monocytes, promonocytes, lymphocytes, granulocytes).
- Ultrafiltration of active serum to estimate molecular weight.
Main Results:
- Serum from mice 18-24 hours post-NBCS injection induced monocytosis in test mice.
- This effect was specific to mononuclear phagocytes.
- The active factor increased promonocyte and bone marrow monocyte numbers, suggesting enhanced monocyte production.
- The factor's molecular weight is below 50,000 Daltons and distinct from the NBCS-derived factor.
Conclusions:
- A transient monocytosis-inducing factor is generated in mouse serum following NBCS administration.
- This factor stimulates monocyte production and is specific for the mononuclear phagocyte lineage.
- The factor's characteristics suggest it is a novel mediator distinct from the initial inflammatory trigger.